tiprankstipranks
Trending News
More News >
Inmed Pharmaceuticals Inc. (INM)
:INM
US Market
Advertisement

InMed Pharmaceuticals (INM) Financial Statements

Compare
379 Followers

InMed Pharmaceuticals Financial Overview

InMed Pharmaceuticals's market cap is currently $5.22M. The company's EPS TTM is $-0.893; its P/E ratio is ―; InMed Pharmaceuticals is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

InMed Pharmaceuticals Debt to Assets

InMed Pharmaceuticals Cash Flow

InMed Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis